Paper32047294
Drug resistance and tolerance in fungi.
Berman J and 1 other. Nat Rev Microbiol, 2020. Cited by 476 papers, by iCite.
Cite this record
ConductScience Library. Drug resistance and tolerance in fungi. Papers, record 32047294. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32047294
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Drug Resistance, Fungal | Major topic |
| Candida | |
| Drug Tolerance | |
| Humans | |
| Microbial Sensitivity Tests |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 340087 | European Research Council | International | PubMed | PubMed | |
| R21AI125094 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 32601439 | Author Correction: Drug resistance and tolerance in fungi. | https://conductscience.org/library/papers/32601439 |
Source PubMed
References121
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28911043 | Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. | J Infect Dis | 2017 | https://conductscience.org/library/papers/28911043 | PubMed |
| 2 | 28774698 | The global problem of antifungal resistance: prevalence, mechanisms, and management. | Lancet Infect Dis | 2017 | https://conductscience.org/library/papers/28774698 | PubMed |
| 3 | 21316001 | Nosocomial fungal infections: epidemiology, infection control, and prevention. | Infect Dis Clin North Am | 2011 | https://conductscience.org/library/papers/21316001 | PubMed |
| 4 | 27643395 | The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). | Transpl Infect Dis | 2016 | https://conductscience.org/library/papers/27643395 | PubMed |
| 5 | 28095189 | The unmet clinical need of novel antifungal drugs. | Virulence | 2017 | https://conductscience.org/library/papers/28095189 | PubMed |
| 6 | 31622115 | Important new therapies for methicillin-resistant Staphylococcus aureus. | Expert Opin Pharmacother | 2019 | https://conductscience.org/library/papers/31622115 | PubMed |
| 7 | 30895218 | Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/30895218 | PubMed |
| 8 | 25384765 | Antifungal pharmacokinetics and pharmacodynamics. | Cold Spring Harb Perspect Med | 2014 | https://conductscience.org/library/papers/25384765 | PubMed |
| 9 | 29941885 | Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia. | Nat Commun | 2018 | https://conductscience.org/library/papers/29941885 | PubMed |
| 10 | 27080241 | Distinguishing between resistance, tolerance and persistence to antibiotic treatment. | Nat Rev Microbiol | 2016 | https://conductscience.org/library/papers/27080241 | PubMed |
| 11 | 30980069 | Definitions and guidelines for research on antibiotic persistence. | Nat Rev Microbiol | 2019 | https://conductscience.org/library/papers/30980069 | PubMed |
| 12 | 28636922 | An Experimental Framework for Quantifying Bacterial Tolerance. | Biophys J | 2017 | https://conductscience.org/library/papers/28636922 | PubMed |
| 13 | 25077667 | ScanLag: high-throughput quantification of colony growth and lag time. | J Vis Exp | 2014 | https://conductscience.org/library/papers/25077667 | PubMed |
| 14 | 30335865 | Fungal persister cells: The basis for recalcitrant infections? | PLoS Pathog | 2018 | https://conductscience.org/library/papers/30335865 | PubMed |
| 15 | 30224538 | Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/30224538 | PubMed |
| 16 | 27161788 | Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates. | Med Mycol | 2016 | https://conductscience.org/library/papers/27161788 | PubMed |
| 17 | 18341604 | Factors influencing the trailing endpoint observed in Candida albicans susceptibility testing using the CLSI procedure. | Clin Microbiol Infect | 2008 | https://conductscience.org/library/papers/18341604 | PubMed |
| 18 | 17577072 | Trailing end-point phenotype of Candida spp. in antifungal susceptibility testing to fluconazole is eliminated by altering incubation temperature. | J Med Microbiol | 2007 | https://conductscience.org/library/papers/17577072 | PubMed |
| 19 | 10348757 | The trailing end point phenotype in antifungal susceptibility testing is pH dependent. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10348757 | PubMed |
| 20 | 26690338 | Defining the frontiers between antifungal resistance, tolerance and the concept of persistence. | Drug Resist Updat | 2015 | https://conductscience.org/library/papers/26690338 | PubMed |
Cited by358
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 476 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42977943 | Isolation, identification and antifungal resistance profile of toxigenic Aspergillus species from marketed dog foods in Ibadan, Nigeria. | BMC Vet Res | 2026 | https://conductscience.org/library/papers/42977943 | PubMed |
| 42974464 | The Plant-Derived Peptide Hyde C1 Exhibits Membrane-Associated Antifungal Activity and Protects Against Systemic Candida albicans Infection. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/42974464 | PubMed |
| 42965713 | Antifungal pharmacotherapy of small intestinal fungal overgrowth: target-site exposure modelling, species-stratified target attainment, and stewardship in a provisional clinicomicrobiological construct. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42965713 | PubMed |
| 42930756 | Adapting to the Host: Physiological Responses, Cell Wall Remodeling, and Persistence in Non-albicans Candida Species. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42930756 | PubMed |
| 42895814 | MARDy 2.0: a platform for exploring and analysing antifungal resistance mutations. | Bioinformatics | 2026 | https://conductscience.org/library/papers/42895814 | PubMed |
| 42881167 | FKS1/2-variant independent mechanisms underlying the emergence of resistance in echinocandin-refractory Candida auris infections. | Nat Commun | 2026 | https://conductscience.org/library/papers/42881167 | PubMed |
| 42875449 | Compound Z247611722 Exhibits Antifungal Activity by Inhibiting Serine Palmitoyltransferase. | Nat Commun | 2026 | https://conductscience.org/library/papers/42875449 | PubMed |
| 42857173 | ER stress selects for Candida auris survivors with acquired fluconazole resistance and caspofungin tolerance. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42857173 | PubMed |
| 42853858 | Diverse genetic pathways drive convergent fluconazole and caspofungin resistance phenotypes in Candida albicans. | PLoS One | 2026 | https://conductscience.org/library/papers/42853858 | PubMed |
| 42799156 | Antifungal and Reactive Oxygen Species Response of Saccharomyces cerevisiae to Deep Eutectic Solvents for Bacterial Nanocellulose-Based Eutectogel. | ACS Phys Chem Au | 2026 | https://conductscience.org/library/papers/42799156 | PubMed |
| 42740829 | Directed biosynthesis of the designer peptidyl nucleoside antibiotics featuring a simplified azetidine-containing moiety. | Synth Syst Biotechnol | 2027 | https://conductscience.org/library/papers/42740829 | PubMed |
| 42725040 | Therapeutic potential of traditional Chinese medicine-derived formulations and extracts in Candida infections: Current trends and future directions. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42725040 | PubMed |
| 42704538 | Beyond antifungal susceptibility: molecular mechanisms, detection, and clinical implications of fungal heteroresistance. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42704538 | PubMed |
| 42663512 | Genotypes, Fluconazole Tolerance and Virulence Phenotypes of Candida albicans Bloodstream Isolates: A Multilocus Sequence Typing-Based Analysis. | Mycoses | 2026 | https://conductscience.org/library/papers/42663512 | PubMed |
| 42656346 | rMAP-Candida: a modular Dockerized WDL/Cromwell workflow for reproducible Candida species typing, assembly-contiguity assessment, antifungal-resistance marker screening, and phylogenomic surveillance. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42656346 | PubMed |
| 42650735 | Early Cellular Responses of Neurospora crassa to Azole Stress: Osmotic Adjustment, Redox Buffering, Sterol-Pathway Feedback, and Cell Wall Remodelling. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42650735 | PubMed |
| 42627630 | Repurposing FDA-Approved Drugs to Inhibit Fungal PPTases for Broad-Spectrum Synergy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42627630 | PubMed |
| 42627176 | Parameters affecting the reliable measurement of fluconazole tolerance using disk diffusion assays with Candida albicans. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42627176 | PubMed |
| 42554648 | NT-A9, a new triazole, exhibits potent antifungal activity against Candida and Cryptococcus species through potent ergosterol biosynthesis inhibition. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42554648 | PubMed |
| 42548818 | In vitro exposure to the agricultural triazole tebuconazole selects for fluconazole cross-resistance and echinocandin tolerance in Candidozyma auris. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42548818 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32047294
GET https://conductscience.org/api/papers/v1/32047294/references?page=2